More recently, GLP-1 producers have begun marketing drugs like Ozempic, Wegovy (both semaglutide), Zepbound or Mounjaro (tirzepatide) for weight loss
For example, in the STEP UP Diabetes trial, participants taking 7.2 mg of semaglutide weekly lost an average of 13.2% of their initial weight, compared to 10.4% for those on the standard 2.4 mg weekly dose
Retatrutide: Not yet approved anywhere, still in clinical trials as of 2024
This could be what you would normally use for nausea or upset stomachsuch as medicines containing bismuth subsalicylate, dimenhydrinate, or diphenhydramineor a ginger-based remedy like Advanced Herbals Ginger Chews that are made with a clinical dose of ginger extract which may provide non-medicated relief from GLP-1 related nausea
What are retatrutide and semaglutide